Skip to main content
. 2020 Jun 21;8(6):935. doi: 10.3390/microorganisms8060935

Table 1.

Antibiotic resistance (AR) profiles of A. baumannii *.

A. baumannii Isolates Number AR Profile Minimal Inhibitory Concentration (MIC) Range Resistant Isolates (%) Hospital Wards/Origin References
164 GEN, AMK 256–≥1024 mg/L

32.1%–83.8%


Endotracheal aspirates, tracheal secretion, wound tampon, pus, sputum, catheters/ ICUs (Intensive Units Care)
[14]
Cephalosporins, Carbapenems
U a
44 PIP, CTX, CAZ/ATM, IMP 0.5–256 mg/L 79.5% U [15]
121 CIP, AMK, AMP–SUL, ATM, CTX, GEN, NET, PIP, TIM, TOB, IMP 0.5–256 mg/L 0%–92.6% Bronchial cultures, burns, blood culture, catheters/ ICUs [16]
375 AMP, PIP, PTZ, CAZ, CTX, IMP, MEM, GEN, AMK, CIP 0.5–>256 mg/L 0%–100% Sputum, wounds/ ICUs [17]
23 CAZ, CTX, FEP, PIP, TZP b, ATM, IMP, MEM, CIP, AMK, GEN, SXT 0.75–>256 (µg mL−1) b 100% U [32]
72 IMP, MEM, FEP, CAZ, SUL, CFP–SUL, PIP, TZP, ATM, CIP, AMK, TIG 4–≥512 mg/L 77.8% ICUs
[36]
100 IMP, MEM, CAZ, CST, TET, TIG, AMP–SUL 0.25–256 (µg/mL) b 0%–100% Sputum, wounds, blood culture, urine, fluids, hemodialysis catheters; ACH (Acute Care Hospital) [37]
204 TIC, TIM, CAZ, FEP, ATM, IMP, TOB, KM, GEN, AMK, PFX, LVX, OFX, CST, TET, FOS U 92% for β-lactams;
47% for IMP
Puncture, pus, blood culture samples/ICUs [41]
20 TIC, CAZ, IMP, MEM 4–>256 µg/mL 90%–100% Tracheal aspirate, bile, urine, burns, respiratory tract, blood culture, sputum/ICUs [38]
100 PIP, AMP/SUL, CIP, AMK, IMP, CTX, FEP, CRO, TET, GEN U 45%–100% Burns, sputum, tracheal secretion, pleural fluid, blood culture, urine, cerebrospinal fluid/ ICU [42]
834 AMC, CIP, GEN, AMK, CFP–SUL, IMP, MEM U 71.7%–96.8% Tracheal aspirate, blood culture, urine, wounds/ICU [43]
15 IMP, MEM, GEN, GEN/NMP, CIP, CIP/NMP, CAZ 0.25–≥256 mg/L U Gastroenterology [44]
155 CIP, FEP, TZP, CAZ, IMP, MEM, AMP/SUL U 93.5%–94.4% Blood respiratory tract secretions, catheter, urine [39]
65 AMK, AMP/SUL, FEP, CST, SXT, DOX, IMP, LVX, MEM, MIN, SUL, TIG, TOB 0.125–256 mg/L 1.5%–96.9% Respiratory tract secretions [24]
59 TIC, PIP, AMP/SUL, TZP, CAZ, FEP, IMP, MEM, CST, GEN, TOB, AMK, MIN, CIP, LVX, SXT U 10.17%–96.61% CCNU (critical care nursing unit); UPU (emergency unit); RE (resuscitation); IM (internal medicine); NE (Nephrology); HO (hematology/Oncology); TC (thoracic cardiology); GS (general surgery); NEO (neonatology) [25]
15 TIC, TIM, PIP, TZP, CAZ, CTX, FEP, MEM, NAL, LVX, CIP, GEN, TOB, AMK, SXT, IMP U (exception MEM and IMP–32 mg/L) 40%–100% Burns, pleural fluid, urine, bronchoalveolar lavage, pus, blood culture [26]
40 CAZ
IMP
GEN
U 92.5%
85%
70%
ICUs, IM, GS [27]
41 AMP/SUL, TZP, CAZ, CRO, FEP, IMP, MEM, GEN, CIP, TIG, AMK 4–≥128 mg/L 34.1%–100% Tracheal aspirate, burns, urine, blood, exudate/ICU [28]
84 GEN, AMK, CRO, FEP, CIP, LVX, CAZ, IMP, MEM, PMB, CST, AMP, TET, TIG, ATM U 0%–100% Wounds [30]
35 Class III Cephalosporins
Class II Cephalosporins
Carbapenems
Aminoglycosides
Fluoroquinolones
U >90%
65%
>90%
60%
90%
Tracheal secretion, urine, cerebrospinal fluid/ICU [31]
8 CAZ, FEP, CTX, CRO, IMP
MEM, TZP, AMP/SUL, GEN, CIP, TIG, CST
1–>128 mg/L 71.4%–100% Blood cultures, urine samples, aspirate sputum, bronchoalveolar lavage fluid, wound swab, pus [21]
41 Aminoglycosides
Β-lactams
Quinolones
Tetracyclines
U 95% Tracheal aspirate, peritoneal fluid, bronchial lavage/ ICU; UPU; NICU (Neonatal Intensive Care Unit) [22]

* Percentage = %; GEN = gentamicin; AMK = amikacin; PIP = piperacillin; CTX = cefotaxime; CAZ/ATM=ceftazidime/aztreonam; IMP = imipenem; CIP = ciprofloxacin; AMP–SUL = ampicillin-sulbactam; ATM = aztreonam; NET = netilmicin; TIM = ticarcillin/clavulanic acid; TOB= tobramycin; AMP = ampicillin; CAZ= ceftazidime; MEM = meropenem; FEP = cefepime; TZP = piperacillin/tazobactam; SXT = cotrimoxazole; SUL = sulbactam; CFP–SUL = cefoperazone/sulbactam; TIG = tigecycline; CST = colistin; TET = tetracycline; TIC = ticarcillin; KM = kanamycin; PFX =pefloxacin; LVX = levofloxacin; OFX = ofloxacin; FOS = fosfomycin; CRO = ceftriaxone; GEN/NMP = gentamicin/ 1-(1-naphtylmethyl)-piperazine; DOX = doxycycline; MIN = minocycline; NAL = nalidixic acid; PMB = polymyxin; a U = unknown; b = according to CSLI criteria.